CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is one of the best emerging technology stocks to buy right now. On September 3, Bank of ...

Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...

Fintel reports that on September 18, 2025, JP Morgan initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...

What you need to know about Ark Invest, an active ETF firm led by Cathie Wood that invests in disruptive, high-growth tech ...

KAIST and the Korea Research Institute of Chemical Technology have jointly developed the world’s first new ‘CRISPR ...

The 2020 Nobel Prize in Chemistry was awarded for the development of CRISPR/Cas9, a method also known as "gene scissors," ...

CRISPR-GPT, a large language model developed at Stanford Medicine, is accelerating gene-editing processes and increasing accessibility to CRISPR.

When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A ...

According to the university, the traditional method of testing for TB involves the collection of sputum, or mucus from the ...

CRISPR Therapeutics (SRSP) stock gains as the company gets a new Overweight rating from J.P. Morgan thanks to its therapeutic ...